Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-022996-79Phase 3Terminated
Phase 3, randomised, open-label trial of sildenafil in erectile dysfunction (ED) (2 arms), sponsored by Fondazione Centro San Raffaele. Primary endpoint: Proportion of patients with IIEF Erectile Function domain score ≥ 22 after washout. Started Dec 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-022996-79.